You are here

Home

Clinical Trials: Lung Disease

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Thursday, August 11, 2022 - 12:00
A Controlled Study to Evaluate the Efficacy of Allogeneic MesenCure for the Treatment of Patients With COVID-related Pneumonia
Condition:   Covid-related Pneumonia
Interventions:   Biological: MesenCure;   Other: Placebo
Sponsor:   BonusBio Group Ltd
Not yet recruiting
Posted: Monday, August 8, 2022 - 12:00
AllogeneiC Expanded Human Mesenchymal Stem Cell Therapy in Patients Recovering From COVID-19 Acute Respiratory Distress (ACE CARD) Trial
Condition:   ARDS, Human
Intervention:   Biological: intravenous delivery of allogeneic bone marrow-derived MSCs
Sponsor:   BioCardia, Inc.
Not yet recruiting
Posted: Tuesday, May 24, 2022 - 12:00
Safety and Effectiveness of Placental Derived Exosomes and Umbilical Cord Mesenchymal Stem Cells in Moderate to Severe Acute Respiratory Distress Syndrome (ARDS) Associated With the Novel Corona Virus Infection (COVID-19)
Conditions:   COVID-19 Acute Respiratory Distress Syndrome;   Respiratory Distress Syndrome
Interventions:   Drug: EV-Pure™ and WJ-Pure™;   Drug: Placebo
Sponsor:   Vitti Labs, LLC
Recruiting
Posted: Friday, April 29, 2022 - 12:00
Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles as Early Goal Directed Therapy for COVID-19 Moderate-to-Severe Acute Respiratory Distress Syndrome (ARDS): A Phase III Clinical Trial
Condition:   COVID-19 Acute Respiratory Distress Syndrome
Intervention:   Drug: EXOFLO
Sponsor:   Direct Biologics, LLC
Not yet recruiting
Posted: Wednesday, April 27, 2022 - 12:00
A First-In-Human Phase 1b Study of AmnioPul-02 in COVID-19
Condition:   COVID-19
Intervention:   Drug: AmnioPul-02
Sponsor:   Amniotics AB
Not yet recruiting
Posted: Friday, March 18, 2022 - 12:00
Mesenchymal Stromal Cells for COVID-19 and Viral Pneumonias
Conditions:   COVID-19 Pneumonia;   Viral Pneumonia
Intervention:   Biological: Allogeneic Mesenchymal Stromal Cells
Sponsors:   Medical University of South Carolina;   Pandorum International, Inc.
Not yet recruiting
Posted: Tuesday, February 8, 2022 - 12:00
Zofin to Treat COVID-19 Long Haulers
Condition:   COVID-19
Interventions:   Drug: Zofin;   Other: Placebo
Sponsors:   Organicell Regenerative Medicine;   Proxima Clinical Research, Inc.
Not yet recruiting
Posted: Monday, January 31, 2022 - 12:00
Efficacy and Safety of EXOSOME-MSC Therapy to Reduce Hyper-inflammation In Moderate COVID-19 Patients
Condition:   SARS-CoV2 Infection
Interventions:   Drug: Exosome-MSC Intravenous injection;   Drug: Placebo Intravenous Injection;   Drug: COVID-19 Standard Treatment
Sponsors:   Dermama Bioteknologi Laboratorium;   Kementerian Riset dan Teknologi / Badan Riset dan Inovasi Nasional, Indonesia
Recruiting
Posted: Tuesday, December 7, 2021 - 12:00
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Pulmonary Diseases
Conditions:   Pulmonary Disease;   Asthma;   Chronic Obstructive Pulmonary Disease
Intervention:   Biological: AlloRx
Sponsor:   The Foundation for Orthopaedics and Regenerative Medicine
Recruiting
Posted: Wednesday, November 24, 2021 - 12:00
Allogenic UCMSCs as Adjuvant Therapy for Severe COVID-19 Patients
Condition:   Covid 19
Interventions:   Biological: Normoxic Allogenic UCMSC;   Other: Normal saline solution
Sponsors:   Kementerian Riset dan Teknologi / Badan Riset dan Inovasi Nasional, Indonesia;   Dr. Moewardi General Hospital, Surakarta, Indonesia;   Dr. Sardjito General Hospital, Yogyakarta, Indonesia;   Dr. Hasan Sadikin General Hospital, Bandung, Indonesia;   PT Bifarma Adiluhung
Recruiting

Pages